Biotech Restructurings Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Restructurings

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: idos	5/25/2007 10:14:13 AM
	of 270

AtheroGenics cuts 50 pct jobs to focus on heart drug Fri May 25, 2007 9:32 AM ET May 25 (Reuters) - Drug company AtheroGenics Inc. <AGIX.O> cut about 50 percent of its workforce in what it said was a first step in new plans for its failed heart drug AGI-1067, it said in a regulatory filing. The company, which now has 67 employees remaining, will announce the full plan on May 31, it said. (Reporting by Varsha Tickoo in Bangalore) yahoo.reuters.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next